Trius to Present at BIO-Europe Spring 2011
March 10, 2011 16:00 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, March 10, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will...
Trius Announces Positive Results From Phase 1 Lung Study of Torezolid Phosphate
February 28, 2011 08:30 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced results from its Phase 1 clinical trial to evaluate the ability of torezolid to penetrate into the...
Trius Therapeutics to Present at March 2011 Investor Conferences
February 24, 2011 16:00 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, Feb. 24, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that the Company will present at the following investor conferences:
Citigroup 2011 Global...
Trius Hires Chief Commercial Officer
January 10, 2011 08:00 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, Jan. 10, 2011 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that J. Craig Thompson has been appointed to the newly created role of Chief Commercial Officer....
Trius to Participate in the Piper Jaffray Health Care Conference
November 29, 2010 16:00 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will...
Trius Therapeutics Reports 2010 Third Quarter Results
November 11, 2010 16:00 ET
|
Trius Therapeutics, Inc.
SAN DIEGO, Nov. 11, 2010 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics...